Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-squamous NSCLC × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1122 Neoplasms 906 Carcinoma, Non-Small-Cell Lung 753 Prostatic Neoplasms 672 Colorectal Neoplasms 510 Lung Neoplasms 489 Neoplasm Metastasis 376 Multiple Myeloma 364 Leukemia, Myeloid, Acute 344 Ovarian Neoplasms 328 Melanoma 310 Pancreatic Neoplasms 289 Squamous Cell Carcinoma of Head and Neck 259 Recurrence 243 Carcinoma, Hepatocellular 233 Brain Neoplasms 231 Stomach Neoplasms 224 Uterine Cervical Neoplasms 205 Lymphoma 205 Glioblastoma 205 Endometrial Neoplasms 203 Precursor Cell Lymphoblastic Leukemia-Lymphoma 197 Head and Neck Neoplasms 197 Urinary Bladder Neoplasms 195 Triple Negative Breast Neoplasms 194 Carcinoma, Renal Cell 183 Leukemia, Lymphocytic, Chronic, B-Cell 170 Hematologic Neoplasms 164 Glioma 164 Colonic Neoplasms 163

Interventions

pyrotinib 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡